Evidence map›Paper›PMID 33118957›Full record

ArticleJMIR research protocols2020

Virtual Reality-Based Treatment for Military Members and Veterans With Combat-Related Posttraumatic Stress Disorder: Protocol for a Multimodular Motion-Assisted Memory Desensitization and Reconsolidation Randomized Controlled Trial.

Chelsea Jones, Lorraine Smith-MacDonald, Antonio Miguel-Cruz, Ashley Pike, Marieke van Gelderen, Liana Lentz, Maria Y Shiu, Emily Tang, Jeffrey Sawalha, Andrew Greenshaw and 6 more

Open access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Chelsea JonesHeroes in Mind, Advocacy and Research Consortium, Faculty of Rehabilitation, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0001-7713-4099
Lorraine Smith-MacDonaldHeroes in Mind, Advocacy and Research Consortium, Faculty of Rehabilitation, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0003-3712-0674
Antonio Miguel-CruzDepartment of Occupational Therapy, Faculty of Rehabilitation, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0003-1618-8733
Ashley PikeHeroes in Mind, Advocacy and Research Consortium, Faculty of Rehabilitation, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0003-3132-4676
Marieke van GelderenARQ Centrum'45, Diemen, Netherlands.ORCID https://orcid.org/0000-0003-4574-8226
Liana LentzSchool of Health Studies, Western University, London, ON, Canada.ORCID https://orcid.org/0000-0003-2356-7467
Maria Y ShiuDefence Research and Development Canada, Toronto Research Centre, Toronto, ON, Canada.ORCID https://orcid.org/0000-0002-4863-3910
Emily TangHeroes in Mind, Advocacy and Research Consortium, Faculty of Rehabilitation, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0001-5260-5632
Jeffrey SawalhaDepartment of Psychiatry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0002-4539-9049
Andrew GreenshawDepartment of Psychiatry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0002-9097-900X
Shawn G RhindDefence Research and Development Canada, Toronto Research Centre, Toronto, ON, Canada.ORCID https://orcid.org/0000-0003-2300-0620
Xin FangDepartment of Obstetrics and Gynecology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0003-3635-6538
Adrian NorbashCanadian Forces Health Services, Department of National Defense, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0003-4471-2280
Rakesh JetlyDepartment of Mental Health, Canadian Forces Health Services, Department of National Defense, Ottawa, ON, Canada.ORCID https://orcid.org/0000-0001-6610-9365
Eric VermettenDepartment of Psychiatry, Leiden University Medical Center, Leiden, Netherlands.ORCID https://orcid.org/0000-0003-0579-4404
Suzette Brémault-PhillipsHeroes in Mind, Advocacy and Research Consortium, Faculty of Rehabilitation, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0003-4167-1815
University of Alberta · CACanadian Armed Forces · CADefence Research and Development Canada · CALeiden University Medical Center · NLWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMilitary members are at elevated risk of operational stress injuries, including posttraumatic stress disorder (PTSD) and moral injury. Although psychotherapy can reduce symptoms, some military members may experience treatment-resistant PTSD. Multimodular motion-assisted memory desensitization and reconsolidation (3MDR) has been introduced as a virtual reality (VR) intervention for military members with PTSD related to military service. The 3MDR intervention incorporates exposure therapy, psychotherapy, eye movement desensitization and reconsolidation, VR, supportive counselling, and treadmill walking.

objectiveThe objective of this study is to investigate whether 3MDR reduces PTSD symptoms among military members with combat-related treatment-resistant PTSD (TR-PTSD); examine the technology acceptance and usability of the Computer Assisted Rehabilitation ENvironment (CAREN) and 3MDR interventions by Canadian Armed Forces service members (CAF-SMs), veterans, 3MDR clinicians, and operators; and evaluate the impact on clinicians and operators of delivering 3MDR.

methodsThis is a mixed-methods waitlist controlled crossover design randomized controlled trial. Participants include both CAF-SMs and veterans (N=40) aged 18-60 years with combat-related TR-PTSD (unsuccessful experience of at least 2 evidence-based trauma treatments). Participants will also include clinicians and operators (N=12) who have been trained in 3MDR and subsequently utilized this intervention with patients. CAF-SMs and veterans will receive 6 weekly 90-minute 3MDR sessions. Quantitative and qualitative data will be collected at baseline and at 1, 3, and 6 months postintervention. Quantitative data collection will include multiomic biomarkers (ie, blood and salivary proteomic and genomic profiles of neuroendocrine, immune-inflammatory mediators, and microRNA), eye tracking, electroencephalography, and physiological data. Data from outcome measures will capture self-reported symptoms of PTSD, moral injury, resilience, and technology acceptance and usability. Qualitative data will be collected from audiovisual recordings of 3MDR sessions and semistructured interviews. Data analysis will include univariate and multivariate approaches, and thematic analysis of treatment sessions and interviews. Machine learning analysis will be included to develop models for the prediction of diagnosis, symptom severity, and treatment outcomes.

resultsThis study commenced in April 2019 and is planned to conclude in April 2021. Study results will guide the further evolution and utilization of 3MDR for military members with TR-PTSD and will have utility in treating other trauma-affected populations.

conclusionsThe goal of this study is to utilize qualitative and quantitative primary and secondary outcomes to provide evidence for the effectiveness and feasibility of 3MDR for treating CAF-SMs and veterans with combat-related TR-PTSD. The results will inform a full-scale clinical trial and stimulate development and adaptation of the protocol to mobile VR apps in supervised clinical settings. This study will add to knowledge of the clinical effectiveness of 3MDR, and provide the first comprehensive analysis of biomarkers, technology acceptance and usability, moral injury, resilience, and the experience of clinicians and operators delivering 3MDR.

trial registrationISRCTN Registry 11264368; http://www.isrctn.com/ISRCTN11264368. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/20620.

Indexed as

3MDRmilitaryposttraumatic stress disorderpsychotherapyveteranvirtual reality

Identifiers

PMID33118957
PMCPMC7661230
OpenAlexW3081949411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.